US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Guardant Health Inc (GH)
Guardant Health Inc (GH) ニュース

GH

Guardant Health (GH)

Guardant Health Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GH

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/14	22 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GH	Guardant Health Inc
2024/06/14	10 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GH	Guardant Health Inc
2024/06/14	09 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GH	Guardant Health Inc
2024/06/14	09 : 54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GH	Guardant Health Inc
2024/06/14	09 : 53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GH	Guardant Health Inc
2024/06/06	05 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GH	Guardant Health Inc
2024/06/05	05 : 12	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:GH	Guardant Health Inc
2024/06/04	21 : 05	Business Wire	Guardant Health introduces new Guardant360 TissueNext test with nearly 500 biomarkers to identify more treatment options for patients with advanced cancer	NASDAQ:GH	Guardant Health Inc
2024/06/04	07 : 25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GH	Guardant Health Inc
2024/06/04	07 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GH	Guardant Health Inc
2024/06/04	07 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GH	Guardant Health Inc
2024/06/03	22 : 18	Business Wire	Guardant Health and Washington University to present study at 2024 ASCO meeting highlighting utility of ctDNA to address racial inequities in the use of targeted therapies and enrollment in clinical trials	NASDAQ:GH	Guardant Health Inc
2024/06/01	05 : 25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GH	Guardant Health Inc
2024/05/31	21 : 05	Business Wire	Guardant Health Named to TIME100 Most Influential Companies	NASDAQ:GH	Guardant Health Inc
2024/05/30	21 : 05	Business Wire	Guardant Health to Present Studies at 2024 ASCO Annual Meeting Highlighting Contributions of Its Blood Tests and Real-World Data to Advancing Precision Oncology and Cancer Screening	NASDAQ:GH	Guardant Health Inc
2024/05/24	20 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GH	Guardant Health Inc
2024/05/24	08 : 03	Business Wire	FDA Advisory Committee Panel Strongly Recommends Approval of Shield™ Blood Test for Colorectal Cancer Screening as a Primary Non-Invasive Screening Option	NASDAQ:GH	Guardant Health Inc
2024/05/23	20 : 05	Business Wire	Guardant Health Stock Trading Temporarily Halted; FDA Panel to Assess Premarket Approval Application for Shield Blood Test for Colorectal Cancer Screening	NASDAQ:GH	Guardant Health Inc
2024/05/23	05 : 05	Business Wire	Guardant Health to Participate in Upcoming Investor Conferences	NASDAQ:GH	Guardant Health Inc
2024/05/21	21 : 44	Business Wire	Guardant Health erhält EU-IVDR-Zertifizierung für Flüssigbiopsie Guardant360® CDx zur Erstellung von Tumormutationsprofilen für alle soliden Krebsarten und therapiebegleitende Diagnostika-Indikationen	NASDAQ:GH	Guardant Health Inc
2024/05/21	21 : 44	Business Wire	Guardant Health reçoit la certification IVDR de l’UE pour la biopsie liquide Guardant360® CDx destinée au profilage des mutations tumorales dans tous les cancers solides et les indications de diagnostic compagnon	NASDAQ:GH	Guardant Health Inc
2024/05/21	21 : 05	Business Wire	Guardant Health Receives EU IVDR Certification for Guardant360® CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic Indications	NASDAQ:GH	Guardant Health Inc
2024/05/17	21 : 05	Business Wire	Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:GH	Guardant Health Inc
2024/05/17	07 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GH	Guardant Health Inc
2024/05/17	07 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GH	Guardant Health Inc
2024/05/16	21 : 05	Business Wire	Guardant Health to present real-world data supporting performance of Shield™ blood test for colorectal cancer screening at 2024 Digestive Disease Week	NASDAQ:GH	Guardant Health Inc
2024/05/10	05 : 59	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GH	Guardant Health Inc
2024/05/10	05 : 11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GH	Guardant Health Inc
2024/05/10	05 : 05	Business Wire	Guardant Health Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance	NASDAQ:GH	Guardant Health Inc
2024/05/08	05 : 05	Business Wire	Guardant Health to Participate in Upcoming Investor Conferences	NASDAQ:GH	Guardant Health Inc

Showing the most relevant articles for your search:NASDAQ:GH

1 2 3 4 5 6 7 8 9 10 次へ >>

Deutsche Telekom (QX)

Health Care Select Sector

BNP Paribas (QX)

American Express

Financial Select Sector

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約